Anti-Thyroid Drugs Global Market Report 2026

Description

Anti-thyroid drugs are agents that work by inhibiting the production of thyroid hormones or by decreasing their activity. Moreover, they are recommended for use in radioactive iodine uptake tests to evaluate thyroid function and protect the thyroid gland in the event of radiation exposure.

The primary categories of anti-thyroid medications include thionamides, which inhibit hormone synthesis, and iodides, which suppress hormone release. Ethionamide drugs work pharmacologically to restore normal thyroid hormone levels. These medications are available for oral and intravenous administration and are supplied through wholesalers and distributors, retail chains, online platforms, and other channels.

Tariffs have increased the cost of imported iodine based compounds and synthetic drug ingredients used in pharmaceutical manufacturing. These impacts are most pronounced in Asia Pacific markets that rely on cross border sourcing for specialty chemical inputs. Rising tariff related expenses have placed pressure on production costs and drug pricing across multiple therapeutic categories. This has influenced procurement decisions and inventory planning for manufacturers and distributors. However, tariffs are also supporting regional pharmaceutical production, local raw material sourcing, and stronger supply chain resilience over the long term.

The anti-thyroid drugs market research report is one of a series of new reports from The Business Research Company that provides anti-thyroid drugs market statistics, including anti-thyroid drugs industry global market size, regional shares, competitors with a anti-thyroid drugs market share, detailed anti-thyroid drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anti-thyroid drugs industry. This anti-thyroid drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti-thyroid drugs market size has grown marginally in recent years. It will grow from $2.49 billion in 2025 to $2.54 billion in 2026 at a compound annual growth rate (CAGR) of 2.0%. The growth in the historic period can be attributed to high prevalence of hyperthyroidism, availability of oral therapies, widespread diagnostic testing, established endocrine care, use in radiation protection.

The anti-thyroid drugs market size is expected to see steady growth in the next few years. It will grow to $2.85 billion in 2030 at a compound annual growth rate (CAGR) of 2.9%. The growth in the forecast period can be attributed to growth in autoimmune thyroid diseases, improved screening programs, rising healthcare access, innovation in thyroid regulation therapies, aging population. Major trends in the forecast period include rising diagnosis of thyroid disorders, growing use of thionamide-based drugs, expansion of outpatient thyroid management, increased monitoring of hormone levels, improved drug safety profiles.

The rising prevalence of thyroid cancer is anticipated to drive the growth of the anti-thyroid drugs market in the coming years. Thyroid cancer is a condition affecting the thyroid gland, located near the base of the throat, which produces hormones that regulate body temperature, heart rate, blood pressure, and weight. The increasing occurrence of thyroid cancer is mainly attributed to higher exposure to medical radiation and environmental carcinogens. Anti-thyroid drugs assist in the early detection of thyroid cancer, which can lead to improved treatment outcomes. For example, in August 2023, the American Society of Clinical Oncology, a US-based community of oncologists and surgeons, reported that in the United States, approximately 43,720 adults (12,540 men and 31,180 women) were diagnosed with thyroid cancer in 2023, with an estimated 2,120 deaths (970 men and 1,150 women) expected in the same year. Consequently, the increasing prevalence of thyroid cancer is driving the growth of the anti-thyroid drugs market.

Major companies operating in the anti-thyroid drugs market are concentrating on developing innovative products, such as monoclonal antibodies, to enhance patient outcomes, minimize adverse effects, and reinforce their competitive edge. Monoclonal antibodies are laboratory-engineered proteins designed to specifically target certain molecules in the body, enabling more effective disease treatment. For example, in March 2025, Innovent Biologics, Inc., a biotechnology company based in China, announced that SYCUME, an anti-IGF-1R monoclonal antibody, received approval from China's National Medical Products Administration (NMPA) for treating thyroid eye disease (TED). SYCUME is the first therapy of its kind approved in China and the second globally, providing a novel, effective treatment that substantially reduces proptosis and inflammation while enhancing patients' quality of life. The approval was based on favorable clinical trial outcomes showing SYCUME's capacity to meet the unmet needs of TED patients, offering a safer and more accessible alternative to current treatments.

In October 2023, Amgen Inc., a US-based biotechnology company, completed the acquisition of Horizon Therapeutics plc for approximately $27.8 billion. Through this acquisition, Amgen intends to strengthen its anti-thyroid drug portfolio by incorporating Horizon Therapeutics' innovative therapies for thyroid disorders, facilitating the development of advanced treatments for patients with hyperthyroidism and other thyroid-related conditions. Horizon Therapeutics plc is an Ireland-based biopharmaceutical company focused on rare and specialty diseases, with a strong history in developing anti-thyroid drugs and therapies for endocrine disorders.

Major companies operating in the anti-thyroid drugs market are Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., Pfizer Inc., Allergan plc, RLC LABS Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Aspen Pharmacare Holdings Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

North America was the largest region in the anti-thyroid drugs market in 2025. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anti-thyroid drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anti-thyroid drugs market consists of sales of levothyroxine, propylthiouracil, and methimazole. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anti-Thyroid Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses anti-thyroid drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anti-thyroid drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The anti-thyroid drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis); Iodides (Inhibition Of Hormone Release)
2) By Route of Administration: Oral; Intravenous; Other Route Of Administration
3) By Distribution Channel: Wholesaler Or Distributors; Retail Chain; Online Distribution; Other Distribution Channels
Subsegments:
1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole; Propylthiouracil
2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide; Lugol's Iodine Solution
Companies Mentioned: Mylan N.V.; Abbott Laboratories; GlaxoSmithKline plc; Merck & Co.; Pfizer Inc.; Allergan plc; RLC LABS Inc.; Lannett Company Inc.; Sanofi S.A.; Novartis AG; Teva Pharmaceutical Industries Ltd.; Aspen Pharmacare Holdings Limited; Aurobindo Pharma Limited; Dr. Reddy's Laboratories Ltd.; Sun Pharmaceutical Industries Ltd.; Cipla Inc.; Lupin Limited; Cadila Healthcare Limited; Torrent Pharmaceuticals Ltd.; Alkem Laboratories Ltd.; Akorn Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH4TATDH02_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Anti-Thyroid Drugs Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Anti-Thyroid Drugs Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Anti-Thyroid Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Anti-Thyroid Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Industry 4.0 & Intelligent Manufacturing
- 4.1.4 Artificial Intelligence & Autonomous Intelligence
- 4.1.5 Sustainability, Climate Tech & Circular Economy
4.2. Major Trends
- 4.2.1 Rising Diagnosis Of Thyroid Disorders
- 4.2.2 Growing Use Of Thionamide-Based Drugs
- 4.2.3 Expansion Of Outpatient Thyroid Management
- 4.2.4 Increased Monitoring Of Hormone Levels
- 4.2.5 Improved Drug Safety Profiles

5. Anti-Thyroid Drugs Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Endocrinology Clinics
5.3 Diagnostic Centers
5.4 Retail Pharmacies
5.5 Specialty Clinics

6. Anti-Thyroid Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Anti-Thyroid Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Anti-Thyroid Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Anti-Thyroid Drugs Market Size, Comparisons And Growth Rate Analysis
7.3. Global Anti-Thyroid Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Anti-Thyroid Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Anti-Thyroid Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Anti-Thyroid Drugs Market Segmentation

9.1. Global Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)
9.2. Global Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Intravenous, Other Route Of Administration
9.3. Global Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels
9.4. Global Anti-Thyroid Drugs Market, Sub-Segmentation Of Thionamides (Inhibition Of Hormone Synthesis), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Methimazole, Propylthiouracil
9.5. Global Anti-Thyroid Drugs Market, Sub-Segmentation Of Iodides (Inhibition Of Hormone Release), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Potassium Iodide, Lugol's Iodine Solution

10. Anti-Thyroid Drugs Market Regional And Country Analysis

10.1. Global Anti-Thyroid Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Anti-Thyroid Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Anti-Thyroid Drugs Market

11.1. Asia-Pacific Anti-Thyroid Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Anti-Thyroid Drugs Market

12.1. China Anti-Thyroid Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Anti-Thyroid Drugs Market

13.1. India Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Anti-Thyroid Drugs Market

14.1. Japan Anti-Thyroid Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Anti-Thyroid Drugs Market

15.1. Australia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Anti-Thyroid Drugs Market

16.1. Indonesia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Anti-Thyroid Drugs Market

17.1. South Korea Anti-Thyroid Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Anti-Thyroid Drugs Market

18.1. Taiwan Anti-Thyroid Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Anti-Thyroid Drugs Market

19.1. South East Asia Anti-Thyroid Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Anti-Thyroid Drugs Market

20.1. Western Europe Anti-Thyroid Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Anti-Thyroid Drugs Market

21.1. UK Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Anti-Thyroid Drugs Market

22.1. Germany Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Anti-Thyroid Drugs Market

23.1. France Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Anti-Thyroid Drugs Market

24.1. Italy Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Anti-Thyroid Drugs Market

25.1. Spain Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Anti-Thyroid Drugs Market

26.1. Eastern Europe Anti-Thyroid Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Anti-Thyroid Drugs Market

27.1. Russia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Anti-Thyroid Drugs Market

28.1. North America Anti-Thyroid Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Anti-Thyroid Drugs Market

29.1. USA Anti-Thyroid Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Anti-Thyroid Drugs Market

30.1. Canada Anti-Thyroid Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Anti-Thyroid Drugs Market

31.1. South America Anti-Thyroid Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Anti-Thyroid Drugs Market

32.1. Brazil Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Anti-Thyroid Drugs Market

33.1. Middle East Anti-Thyroid Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Anti-Thyroid Drugs Market

34.1. Africa Anti-Thyroid Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Anti-Thyroid Drugs Market Regulatory and Investment Landscape

36. Anti-Thyroid Drugs Market Competitive Landscape And Company Profiles

36.1. Anti-Thyroid Drugs Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Anti-Thyroid Drugs Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Anti-Thyroid Drugs Market Company Profiles
- 36.3.1. Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Anti-Thyroid Drugs Market Other Major And Innovative Companies

Allergan plc, RLC LABS Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Aspen Pharmacare Holdings Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd.

38. Global Anti-Thyroid Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Anti-Thyroid Drugs Market

40. Anti-Thyroid Drugs Market High Potential Countries, Segments and Strategies

40.1 Anti-Thyroid Drugs Market In 2030 - Countries Offering Most New Opportunities
40.2 Anti-Thyroid Drugs Market In 2030 - Segments Offering Most New Opportunities
40.3 Anti-Thyroid Drugs Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer